Nektar Therapeutics (Pulmonary Drug Delivery Business) Overview

  • Status

  • Acquired/​Merged

  • Employees

  • 140

Employees
  • Latest Deal Type

  • M&A

  • Financing Rounds

  • 1

Nektar Therapeutics (Pulmonary Drug Delivery Business) General Information

Description

Provider of pulmonary medical devices. The company engages in selling of pulmonary delivery assets, technology, pulmonary therapeutics, medical devices and others in United States.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Acquirer
Novartis
Primary Office
  • 455 Mission Bay Boulevard South
  • San Francisco, CA 94158
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nektar Therapeutics (Pulmonary Drug Delivery Business) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Nektar Therapeutics (Pulmonary Drug Delivery Business)‘s full profile, request access.

Request a free trial

Nektar Therapeutics (Pulmonary Drug Delivery Business) Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nektar Therapeutics (Pulmonary Drug Delivery Business) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Nektar Therapeutics (Pulmonary Drug Delivery Business)‘s full profile, request access.

Request a free trial